© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
January 19, 2022
Matthew Brunner, MHS, PA-C, DFAAPA, highlights the most anticipated developments in the field of treating patients with plaque psoriasis.
Stratification of patients for the treatment of plaque psoriasis based on comorbidities and prior biologic experience.
January 12, 2022
Advanced practice providers discuss scenarios in which they would consider switching between therapies when treating patients with plaque psoriasis.
Lakshi Aldredge, MSN, ANP-BC, DCNP, and Matthew Brunner, MHS, PA-C, DFAAPA share their personal experiences with using IL-23 inhibitors in treating patients with plaque psoriasis.
Research Suggests Pediatric Psoriasis Linked to Anxiety, Depression
Esketamine Infusion May Prevent Post-Surgery Sleep Disturbances
Study Suggests PCSK9 Inhibitors May Reduce Psoriasis Risk